Manatuck Hill Partners’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
RIM
FLAM
EA
EMFAT
BFA
Manatuck Hill Partners's ATRC Position: Q1 2016 in Review
Manatuck Hill Partners sold out of AtriCure (ATRC) in Q1 2016, closing a stake of 86,200 shares — an estimated $1.93M sold.
Manatuck Hill Partners first reported a position in ATRC in Q2 2013 and held it in 11 quarters. The position peaked at $5.76M in Q1 2014. 113 funds tracked by Wall St. Rank hold ATRC as of Q1 2016.
- Manatuck Hill Partners reported no remaining AtriCure position as of Q1 2016 after selling out during the quarter.
- Manatuck Hill Partners sold 86,200 AtriCure shares in Q1 2016, an estimated $1.93M.
- Manatuck Hill Partners first reported a position in AtriCure in Q2 2013 and held it in 11 quarters.
- Manatuck Hill Partners's AtriCure position peaked at $5.76M in Q1 2014.
- 113 funds tracked by Wall St. Rank held AtriCure as of Q1 2016.
Based on Manatuck Hill Partners's 13F filing for Q1 2016, filed 16 May 2016.